
LINK . SPRINGER . COM {
}
Title:
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist | Cancer Immunology, Immunotherapy
Description:
Background The in-situ vaccine using CpG oligodeoxynucleotide combined with OX40 agonist antibody (CpG + OX40) has been shown to be an effective therapy activating an anti-tumor T cell response in certain settings. The roles of tumor volume, tumor model, and the addition of checkpoint blockade in the efficacy of CpG + OX40 in-situ vaccination remains unknown. Methods Mice bearing flank tumors (B78 melanoma or A20 lymphoma) were treated with combinations of CpG, OX40, and anti-CTLA-4. Tumor growth and survival were monitored. In vivo T cell depletion, tumor cell phenotype, and tumor infiltrating lymphocyte (TIL) studies were performed. Tumor cell sensitivity to CpG and macrophages were evaluated in vitro. Results As tumor volumes increased in the B78 (one-tumor) and A20 (one-tumor or two-tumor) models, the anti-tumor efficacy of the in-situ vaccine decreased. In vitro, CpG had a direct effect on A20 proliferation and phenotype and an indirect effect on B78 proliferation via macrophage activation. As A20 tumors progressed in vivo, tumor cell phenotype changed, and T cells became more involved in the local CpG + OX40 mediated anti-tumor response. In mice with larger tumors that were poorly responsive to CpG + OX40, the addition of anti-CTLA-4 enhanced the anti-tumor efficacy in the A20 but not B78 models. Conclusions Increased tumor volume negatively impacts the anti-tumor capability of CpG + OX40 in-situ vaccine. The addition of checkpoint blockade augmented the efficacy of CpG + OX40 in the A20 but not B78 model. These results highlight the importance of considering multiple preclinical model conditions when assessing the efficacy of cancer immunotherapy regimens and their translation to clinical testing.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure if the website is profiting.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
tumor, cpg, tumors, mice, fig, cells, pubmed, cell, antitumor, article, model, response, large, cancer, small, google, scholar, treated, local, models, survival, untreated, cas, data, antictla, immunotherapy, volume, insitu, effect, size, preclinical, distant, immune, significantly, vaccine, shown, efficacy, twotumor, progression, treatment, central, systemic, expression, calculated, average, pbs, bearing, macrophages, experiments, significant,
Topics {✒️}
t-cell-inflamed tumor microenvironment cpg + ox40 + cd4 depletion + cd8 depletion emerging evidence suggest article download pdf cd45 + /cd3 + /cd4 + /cd25 + /foxp3 + myeloid-derived suppressor cells triplicate wells ± standard error delivering intra-tumor injectables tnfr-related molecule ox40 cytotoxic t-cell response increasing ifn-γ expression [3h]thymidine incorporation assay strong anti-tumor response anti-tumor immune response strongest anti-tumor effect significant anti-tumor response direct anti-proliferative effects enhanced anti-tumor response significant anti-tumor effect intra-experimental media average systemic anti-tumor response time-weighted average analysis full size image local anti-tumor response tumor-curing immune response systemic anti-tumor effect systemic anti-tumor effects integrated dna technologies local anti-tumor effect t-cell modulation combined cpg + ox40 + rat igg cpg + ox40 + anti-ctla-4 cpg + ox40 cures mice macrophage anti-tumor effect depleting tumor-specific tregs concomitant immune tolerance cpg + ox40 lost effectiveness situ vaccine cpg + ox40 predict therapy response privacy choices/manage cookies tumor-specific inhibition sagiv-barfi immune checkpoint blockade cpg increases immune data suggest cpg + ox40 related subjects full access tumor burden increases flow cytometry analysis checkpoint blockade augmented
Questions {❓}
- Adams CP, Brantner VV (2006) Estimating the cost of new drug development: is it really 802 million dollars?
Schema {🗺️}
WebPage:
mainEntity:
headline:Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist
description:The in-situ vaccine using CpG oligodeoxynucleotide combined with OX40 agonist antibody (CpG + OX40) has been shown to be an effective therapy activating an anti-tumor T cell response in certain settings. The roles of tumor volume, tumor model, and the addition of checkpoint blockade in the efficacy of CpG + OX40 in-situ vaccination remains unknown. Mice bearing flank tumors (B78 melanoma or A20 lymphoma) were treated with combinations of CpG, OX40, and anti-CTLA-4. Tumor growth and survival were monitored. In vivo T cell depletion, tumor cell phenotype, and tumor infiltrating lymphocyte (TIL) studies were performed. Tumor cell sensitivity to CpG and macrophages were evaluated in vitro. As tumor volumes increased in the B78 (one-tumor) and A20 (one-tumor or two-tumor) models, the anti-tumor efficacy of the in-situ vaccine decreased. In vitro, CpG had a direct effect on A20 proliferation and phenotype and an indirect effect on B78 proliferation via macrophage activation. As A20 tumors progressed in vivo, tumor cell phenotype changed, and T cells became more involved in the local CpG + OX40 mediated anti-tumor response. In mice with larger tumors that were poorly responsive to CpG + OX40, the addition of anti-CTLA-4 enhanced the anti-tumor efficacy in the A20 but not B78 models. Increased tumor volume negatively impacts the anti-tumor capability of CpG + OX40 in-situ vaccine. The addition of checkpoint blockade augmented the efficacy of CpG + OX40 in the A20 but not B78 model. These results highlight the importance of considering multiple preclinical model conditions when assessing the efficacy of cancer immunotherapy regimens and their translation to clinical testing.
datePublished:2023-04-05T00:00:00Z
dateModified:2023-04-05T00:00:00Z
pageStart:2459
pageEnd:2471
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-023-03433-3
keywords:
In-situ vaccine
CpG
OX40 agonist
Anti-CTLA-4
Preclinical tumor progression
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig6_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:72
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Alexander A. Pieper
url:http://orcid.org/0000-0001-5288-8214
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Dan V. Spiegelman
url:http://orcid.org/0000-0001-6450-3238
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Mildred A. R. Felder
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Arika S. Feils
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Noah W. Tsarovsky
url:http://orcid.org/0000-0001-9036-3515
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Jen Zaborek
url:http://orcid.org/0000-0002-5247-0632
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Zachary S. Morris
url:http://orcid.org/0000-0001-5558-3547
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Amy K. Erbe
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Alexander L. Rakhmilevich
url:http://orcid.org/0000-0002-2686-9500
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Paul M. Sondel
url:http://orcid.org/0000-0002-0981-8875
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:4159 MACC Fund UW Childhood Cancer Research Wing, Wisconsin Institute for Medical Research, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist
description:The in-situ vaccine using CpG oligodeoxynucleotide combined with OX40 agonist antibody (CpG + OX40) has been shown to be an effective therapy activating an anti-tumor T cell response in certain settings. The roles of tumor volume, tumor model, and the addition of checkpoint blockade in the efficacy of CpG + OX40 in-situ vaccination remains unknown. Mice bearing flank tumors (B78 melanoma or A20 lymphoma) were treated with combinations of CpG, OX40, and anti-CTLA-4. Tumor growth and survival were monitored. In vivo T cell depletion, tumor cell phenotype, and tumor infiltrating lymphocyte (TIL) studies were performed. Tumor cell sensitivity to CpG and macrophages were evaluated in vitro. As tumor volumes increased in the B78 (one-tumor) and A20 (one-tumor or two-tumor) models, the anti-tumor efficacy of the in-situ vaccine decreased. In vitro, CpG had a direct effect on A20 proliferation and phenotype and an indirect effect on B78 proliferation via macrophage activation. As A20 tumors progressed in vivo, tumor cell phenotype changed, and T cells became more involved in the local CpG + OX40 mediated anti-tumor response. In mice with larger tumors that were poorly responsive to CpG + OX40, the addition of anti-CTLA-4 enhanced the anti-tumor efficacy in the A20 but not B78 models. Increased tumor volume negatively impacts the anti-tumor capability of CpG + OX40 in-situ vaccine. The addition of checkpoint blockade augmented the efficacy of CpG + OX40 in the A20 but not B78 model. These results highlight the importance of considering multiple preclinical model conditions when assessing the efficacy of cancer immunotherapy regimens and their translation to clinical testing.
datePublished:2023-04-05T00:00:00Z
dateModified:2023-04-05T00:00:00Z
pageStart:2459
pageEnd:2471
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-023-03433-3
keywords:
In-situ vaccine
CpG
OX40 agonist
Anti-CTLA-4
Preclinical tumor progression
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_Fig6_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:72
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Alexander A. Pieper
url:http://orcid.org/0000-0001-5288-8214
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Dan V. Spiegelman
url:http://orcid.org/0000-0001-6450-3238
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Mildred A. R. Felder
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Arika S. Feils
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Noah W. Tsarovsky
url:http://orcid.org/0000-0001-9036-3515
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Jen Zaborek
url:http://orcid.org/0000-0002-5247-0632
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Zachary S. Morris
url:http://orcid.org/0000-0001-5558-3547
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Amy K. Erbe
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Alexander L. Rakhmilevich
url:http://orcid.org/0000-0002-2686-9500
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Paul M. Sondel
url:http://orcid.org/0000-0002-0981-8875
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:4159 MACC Fund UW Childhood Cancer Research Wing, Wisconsin Institute for Medical Research, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:72
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:4159 MACC Fund UW Childhood Cancer Research Wing, Wisconsin Institute for Medical Research, University of Wisconsin, Madison, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Alexander A. Pieper
url:http://orcid.org/0000-0001-5288-8214
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Dan V. Spiegelman
url:http://orcid.org/0000-0001-6450-3238
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Mildred A. R. Felder
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Arika S. Feils
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Noah W. Tsarovsky
url:http://orcid.org/0000-0001-9036-3515
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Jen Zaborek
url:http://orcid.org/0000-0002-5247-0632
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Zachary S. Morris
url:http://orcid.org/0000-0001-5558-3547
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Amy K. Erbe
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Alexander L. Rakhmilevich
url:http://orcid.org/0000-0002-2686-9500
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Paul M. Sondel
url:http://orcid.org/0000-0002-0981-8875
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:4159 MACC Fund UW Childhood Cancer Research Wing, Wisconsin Institute for Medical Research, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, USA
name:4159 MACC Fund UW Childhood Cancer Research Wing, Wisconsin Institute for Medical Research, University of Wisconsin, Madison, USA
External Links {🔗}(186)
- What's the total monthly financial gain of https://www.springernature.com/gp/authors?
- Check the income stats for https://link.springernature.com/home/
- What's the total monthly financial gain of https://order.springer.com/public/cart?
- How much cash flow does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research have monthly?
- How much does https://submission.nature.com/new-submission/262/3 rake in every month?
- What's the financial gain of https://orcid.org/0000-0001-5288-8214?
- How much does https://orcid.org/0000-0001-6450-3238 pull in?
- How much cash flow does https://orcid.org/0000-0001-9036-3515 have monthly?
- How much money does https://orcid.org/0000-0002-5247-0632 make?
- Earnings of https://orcid.org/0000-0001-5558-3547
- Monthly income for https://orcid.org/0000-0002-2686-9500
- What is the earnings of https://orcid.org/0000-0002-0981-8875?
- What is the monthly revenue of https://beta.springernature.com/pre-submission?journalId=262?
- What's the financial gain of https://doi.org/10.1158%2F1078-0432.CCR-17-2386?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29685882 each month?
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916264's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Baseline%20tumor%20size%20is%20an%20independent%20prognostic%20factor%20for%20overall%20survival%20in%20patients%20with%20melanoma%20treated%20with%20pembrolizumab&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-17-2386&volume=24&issue=20&pages=4960-4967&publication_year=2018&author=Joseph%2CRW&author=Elassaiss-Schaap%2CJ&author=Kefford%2CR bring in each month?
- What's the total monthly financial gain of https://doi.org/10.21873%2Fanticanres.13180?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30711962?
- How much does http://scholar.google.com/scholar_lookup?&title=Baseline%20tumor%20size%20as%20a%20predictive%20and%20prognostic%20factor%20of%20immune%20checkpoint%20inhibitor%20therapy%20for%20non-small%20cell%20lung%20cancer&journal=Anticancer%20Res&doi=10.21873%2Fanticanres.13180&volume=39&issue=2&pages=815-825&publication_year=2019&author=Katsurada%2CM&author=Nagano%2CT&author=Tachihara%2CM rake in every month?
- What's the financial intake of https://doi.org/10.1038%2Fs41598-019-52913-z?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31729430
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858444
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=A%20rationale%20for%20surgical%20debulking%20to%20improve%20anti-PD1%20therapy%20outcome%20in%20non%20small%20cell%20lung%20cancer&journal=Sci%20Rep&doi=10.1038%2Fs41598-019-52913-z&volume=9&issue=1&publication_year=2019&author=Guisier%2CF&author=Cousse%2CS&author=Jeanvoine%2CM?
- What's the financial gain of https://doi.org/10.1371%2Fjournal.pone.0206223?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30388137 generate?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214511 make?
- http://scholar.google.com/scholar_lookup?&title=Tumor-immune%20profiling%20of%20murine%20syngeneic%20tumor%20models%20as%20a%20framework%20to%20guide%20mechanistic%20studies%20and%20predict%20therapy%20response%20in%20distinct%20tumor%20microenvironments&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0206223&volume=13&issue=11&publication_year=2018&author=Yu%2CJW&author=Bhattacharya%2CS&author=Yanamandra%2CN's financial summary
- https://doi.org/10.3389%2Ffimmu.2020.629722's financial summary
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33597954 earns monthly
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Tumor%20burden%20and%20immunotherapy%3A%20impact%20on%20immune%20infiltration%20and%20therapeutic%20outcomes&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2020.629722&volume=11&publication_year=2020&author=Kim%2CSI&author=Cassella%2CCR&author=Byrne%2CKT have monthly?
- Learn about the earnings of https://doi.org/10.1053%2Fj.seminoncol.2015.05.011
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26320069?
- How much income is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555998 earning monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20next%20hurdle%20in%20cancer%20immunotherapy%3A%20overcoming%20the%20non-T-cell-inflamed%20tumor%20microenvironment&journal=Semin%20Oncol&doi=10.1053%2Fj.seminoncol.2015.05.011&volume=42&issue=4&pages=663-671&publication_year=2015&author=Gajewski%2CTF?
- Explore the financials of https://doi.org/10.1016%2Fj.lungcan.2021.10.002
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34666276
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=The%20effect%20of%20tumor%20size%20and%20metastatic%20extent%20on%20the%20efficacy%20of%20first%20line%20pembrolizumab%20monotherapy%20in%20patients%20with%20high%20PD-L1%20expressing%20advanced%20NSCLC%20tumors&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2021.10.002&volume=162&pages=36-41&publication_year=2021&author=Schakenraad%2CA&author=Hashemi%2CS&author=Twisk%2CJ have monthly?
- What's the financial gain of https://doi.org/10.1038%2F8426?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10229232's revenue stream
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=CD40%20antibody%20evokes%20a%20cytotoxic%20T-cell%20response%20that%20eradicates%20lymphoma%20and%20bypasses%20T-cell%20help&journal=Nat%20Med&doi=10.1038%2F8426&volume=5&issue=5&pages=548-553&publication_year=1999&author=French%2CRR&author=Chan%2CHT&author=Tutt%2CAL
- Income figures for https://doi.org/10.1158%2F0008-5472.CAN-15-2644
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27197149
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930687?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=In%20situ%20tumor%20vaccination%20by%20combining%20local%20radiation%20and%20tumor-specific%20antibody%20or%20immunocytokine%20treatments&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-15-2644&volume=76&issue=13&pages=3929-3941&publication_year=2016&author=Morris%2CZS&author=Guy%2CEI&author=Francis%2CDM
- Monthly income for https://doi.org/10.1172%2FJCI64859
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23728179
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668834 bring in?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Depleting%20tumor-specific%20Tregs%20at%20a%20single%20site%20eradicates%20disseminated%20tumors&journal=J%20Clin%20Invest&doi=10.1172%2FJCI64859&volume=123&issue=6&pages=2447-2463&publication_year=2013&author=Marabelle%2CA&author=Kohrt%2CH&author=Sagiv-Barfi%2CI bring in?
- How much income does https://doi.org/10.2147%2FOTT.S247050 have?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33116588 generate?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553670 pull in monthly?
- http://scholar.google.com/scholar_lookup?&title=Toll-like%20receptor%209%20agonists%20in%20cancer&journal=Onco%20Targets%20Ther&doi=10.2147%2FOTT.S247050&volume=13&pages=10039-10060&publication_year=2020&author=Karapetyan%2CL&author=Luke%2CJJ&author=Davar%2CD's total income per month
- https://doi.org/10.1002%2Feji.1830260805 income
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8765008 generate?
- What's http://scholar.google.com/scholar_lookup?&title=OX40%20is%20differentially%20expressed%20on%20activated%20rat%20and%20mouse%20T%20cells%20and%20is%20the%20sole%20receptor%20for%20the%20OX40%20ligand&journal=Eur%20J%20Immunol&doi=10.1002%2Feji.1830260805&volume=26&issue=8&pages=1695-1659&publication_year=1996&author=al-Shamkhani%2CA&author=Birkeland%2CML&author=Puklavec%2CM's gross income?
- How much money does https://doi.org/10.4049%2Fjimmunol.165.6.3043 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10975814 earn?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20OX40%20costimulatory%20receptor%20determines%20the%20development%20of%20CD4%20memory%20by%20regulating%20primary%20clonal%20expansion&journal=J%20Immunol&doi=10.4049%2Fjimmunol.165.6.3043&volume=165&issue=6&pages=3043-3050&publication_year=2000&author=Gramaglia%2CI&author=Jember%2CA&author=Pippig%2CSD?
- What are the total earnings of https://doi.org/10.1146%2Fannurev-immunol-030409-101243?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20307208?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882161 rake in every month?
- See how much http://scholar.google.com/scholar_lookup?&title=Control%20of%20immunity%20by%20the%20TNFR-related%20molecule%20OX40%20%28CD134%29&journal=Annu%20Rev%20Immunol&doi=10.1146%2Fannurev-immunol-030409-101243&volume=28&pages=57-78&publication_year=2010&author=Croft%2CM makes per month
- What's the financial outcome of https://doi.org/10.1182%2Fblood-2007-01-070748?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17575071
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1988917 make?
- Profit of http://scholar.google.com/scholar_lookup?&title=OX40%20costimulation%20turns%20off%20Foxp3%2B%20Tregs&journal=Blood&doi=10.1182%2Fblood-2007-01-070748&volume=110&issue=7&pages=2501-2510&publication_year=2007&author=Vu%2CMD&author=Xiao%2CX&author=Gao%2CW
- What's the financial outcome of https://doi.org/10.1073%2Fpnas.0603107103?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16924108 have monthly?
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559766
- http://scholar.google.com/scholar_lookup?&title=OX40%20ligand%20shuts%20down%20IL-10-producing%20regulatory%20T%20cells&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.0603107103&volume=103&issue=35&pages=13138-13143&publication_year=2006&author=Ito%2CT&author=Wang%2CYH&author=Duramad%2CO's revenue stream
- Get to know https://doi.org/10.1038%2Ficb.2014.26's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24732076 net monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=OX40%20engagement%20depletes%20intratumoral%20Tregs%20via%20activating%20FcgammaRs%2C%20leading%20to%20antitumor%20efficacy&journal=Immunol%20Cell%20Biol&doi=10.1038%2Ficb.2014.26&volume=92&issue=6&pages=475-480&publication_year=2014&author=Bulliard%2CY&author=Jolicoeur%2CR&author=Zhang%2CJ generate?
- How much does https://doi.org/10.3389%2Ffimmu.2021.763888 earn?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34868010?
- What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634717's gross income?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Radiation%20augments%20the%20local%20anti-tumor%20effect%20of%20in%20situ%20vaccine%20with%20CpG-oligodeoxynucleotides%20and%20anti-OX40%20in%20immunologically%20cold%20tumor%20models&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2021.763888&volume=12&publication_year=2021&author=Pieper%2CAA&author=Zangl%2CLM&author=Speigelman%2CDV?
- How much does https://doi.org/10.4049%2Fjimmunol.1601255 bring in each month?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28062694?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Effective%20combination%20of%20innate%20and%20adaptive%20immunotherapeutic%20approaches%20in%20a%20mouse%20melanoma%20model&journal=J%20Immunol&doi=10.4049%2Fjimmunol.1601255&volume=198&issue=4&pages=1575-1584&publication_year=2017&author=Rakhmilevich%2CAL&author=Felder%2CM&author=Lever%2CL is on a monthly basis
- How much money does https://doi.org/10.4049%2Fjimmunol.176.1.309 generate?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16365423 have monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Synergistic%20activation%20of%20macrophages%20via%20CD40%20and%20TLR9%20results%20in%20T%20cell%20independent%20antitumor%20effects&journal=J%20Immunol&doi=10.4049%2Fjimmunol.176.1.309&volume=176&issue=1&pages=309-318&publication_year=2006&author=Buhtoiarov%2CIN&author=Lum%2CHD&author=Berke%2CG
- Get to know https://doi.org/10.4049%2Fjimmunol.179.4.2493's earnings
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17675511's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Lymphoma%20immunotherapy%20with%20CpG%20oligodeoxynucleotides%20requires%20TLR9%20either%20in%20the%20host%20or%20in%20the%20tumor%20itself&journal=J%20Immunol&doi=10.4049%2Fjimmunol.179.4.2493&volume=179&issue=4&pages=2493-2500&publication_year=2007&author=Li%2CJ&author=Song%2CW&author=Czerwinski%2CDK net monthly?
- What's the monthly income of https://doi.org/10.1189%2Fjlb.69.1.81?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11200072 bring in each month?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=CpG%20DNA%20increases%20primary%20malignant%20B%20cell%20expression%20of%20costimulatory%20molecules%20and%20target%20antigens&journal=J%20Leukoc%20Biol&doi=10.1189%2Fjlb.69.1.81&volume=69&issue=1&pages=81-88&publication_year=2001&author=Jahrsdorfer%2CB&author=Hartmann%2CG&author=Racila%2CE?
- Financial intake of https://doi.org/10.1126%2Fscience.1202947
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21474713 gross monthly?
- How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198051 have?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Trans-endocytosis%20of%20CD80%20and%20CD86%3A%20a%20molecular%20basis%20for%20the%20cell-extrinsic%20function%20of%20CTLA-4&journal=Science&doi=10.1126%2Fscience.1202947&volume=332&issue=6029&pages=600-603&publication_year=2011&author=Qureshi%2COS&author=Zheng%2CY&author=Nakamura%2CK make?
- Check the income stats for https://doi.org/10.1158%2F2326-6066.CIR-17-0353
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29748391 make?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030484?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-specific%20inhibition%20of%20in%20situ%20vaccination%20by%20distant%20untreated%20tumor%20sites&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-17-0353&volume=6&issue=7&pages=825-834&publication_year=2018&author=Morris%2CZS&author=Guy%2CEI&author=Werner%2CLR pull in monthly?
- How much does https://doi.org/10.1016%2Fj.hoc.2006.03.001 rake in every month?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16762725?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Cancer%20immunotherapy%20and%20preclinical%20studies%3A%20why%20we%20are%20not%20wasting%20our%20time%20with%20animal%20experiments&journal=Hematol%20Oncol%20Clin%20North%20Am&doi=10.1016%2Fj.hoc.2006.03.001&volume=20&issue=3&pages=567-584&publication_year=2006&author=Schreiber%2CK&author=Rowley%2CDA&author=Riethm%C3%BCller%2CG
- What's the income of https://doi.org/10.1038%2Fs41591-020-0892-6?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32451499
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384250 generate?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Systemic%20dysfunction%20and%20plasticity%20of%20the%20immune%20macroenvironment%20in%20cancer%20models&journal=Nat%20Med&doi=10.1038%2Fs41591-020-0892-6&volume=26&issue=7&pages=1125-1134&publication_year=2020&author=Allen%2CBM&author=Hiam%2CKJ&author=Burnett%2CCE
- What's the financial gain of https://doi.org/10.1054%2Fbjoc.2001.1796?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11355958?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363645 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Relationships%20between%20drug%20activity%20in%20NCI%20preclinical%20in%20vitro%20and%20in%20vivo%20models%20and%20early%20clinical%20trials&journal=Br%20J%20Cancer&doi=10.1054%2Fbjoc.2001.1796&volume=84&issue=10&pages=1424-1431&publication_year=2001&author=Johnson%2CJI&author=Decker%2CS&author=Zaharevitz%2CD rake in every month?
- What's the total monthly financial gain of https://doi.org/10.1377%2Fhlthaff.25.2.420?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16522582?
- How much does http://scholar.google.com/scholar_lookup?&title=Estimating%20the%20cost%20of%20new%20drug%20development%3A%20is%20it%20really%20802%20million%20dollars%3F&journal=Health%20Aff%20%28Millwood%29&doi=10.1377%2Fhlthaff.25.2.420&volume=25&issue=2&pages=420-428&publication_year=2006&author=Adams%2CCP&author=Brantner%2CVV net monthly?
- How much revenue does https://doi.org/10.1038%2Fnrd2110 generate?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16915232?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20mighty%20mouse%3A%20genetically%20engineered%20mouse%20models%20in%20cancer%20drug%20development&journal=Nat%20Rev%20Drug%20Discov&doi=10.1038%2Fnrd2110&volume=5&issue=9&pages=741-754&publication_year=2006&author=Sharpless%2CNE&author=Depinho%2CRA gross monthly?
- How much income does https://doi.org/10.1111%2Fj.1365-2567.2006.02517.x have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17163960 make?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265883
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Macrophages%20are%20essential%20for%20antitumour%20effects%20against%20weakly%20immunogenic%20murine%20tumours%20induced%20by%20class%20B%20CpG-oligodeoxynucleotides&journal=Immunology&doi=10.1111%2Fj.1365-2567.2006.02517.x&volume=120&issue=3&pages=412-423&publication_year=2007&author=Buhtoiarov%2CIN&author=Sondel%2CPM&author=Eickhoff%2CJC
- How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-13-2508 bring in?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24323899's gross income?
- What's http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20predict%20survival%20of%20patients%20with%20advanced%20melanoma%3A%20comparison%20with%20regulatory%20T%20cells%20and%20NY-ESO-1-%20or%20melan-A-specific%20T%20cells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-13-2508&volume=20&issue=6&pages=1601-1609&publication_year=2014&author=Weide%2CB&author=Martens%2CA&author=Zelba%2CH's gross income?
- https://doi.org/10.1016%2Fj.blre.2018.04.006's financial summary
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29691090
- How much does http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20in%20lymphoma%3A%20the%20good%2C%20the%20bad%20and%20the%20ugly&journal=Blood%20Rev&doi=10.1016%2Fj.blre.2018.04.006&volume=32&issue=6&pages=490-498&publication_year=2018&author=Betsch%2CA&author=Rutgeerts%2CO&author=Fevery%2CS pull in?
- What's the monthly money flow for https://doi.org/10.1080%2F2162402X.2018.1494113?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30288362 produce monthly?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169582 make?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Prognostic%20role%20of%20pretreatment%20circulating%20MDSCs%20in%20patients%20with%20solid%20malignancies%3A%20a%20meta-analysis%20of%2040%20studies&journal=Oncoimmunology&doi=10.1080%2F2162402X.2018.1494113&volume=7&issue=10&publication_year=2018&author=Wang%2CPF&author=Song%2CSY&author=Wang%2CTJ?
- Get to know what's the income of https://doi.org/10.1158%2F1078-0432.CCR-10-2672
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21233400 have monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=CpG%20blocks%20immunosuppression%20by%20myeloid-derived%20suppressor%20cells%20in%20tumor-bearing%20mice&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-10-2672&volume=17&issue=7&pages=1765-1775&publication_year=2011&author=Zoglmeier%2CC&author=Bauer%2CH&author=Noerenberg%2CD earning monthly?
- How much does https://doi.org/10.1158%2F2159-8290.CD-18-0367 generate monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30115704?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Fundamental%20mechanisms%20of%20immune%20checkpoint%20blockade%20therapy&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-18-0367&volume=8&issue=9&pages=1069-1086&publication_year=2018&author=Wei%2CSC&author=Duffy%2CCR&author=Allison%2CJP?
- How much does https://doi.org/10.1182%2Fbloodadvances.2018020040 rake in every month?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30194137
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134215 earns monthly
- How much money does http://scholar.google.com/scholar_lookup?&title=Enhancing%20immunotherapy%20of%20STING%20agonist%20for%20lymphoma%20in%20preclinical%20models&journal=Blood%20Adv&doi=10.1182%2Fbloodadvances.2018020040&volume=2&issue=17&pages=2230-2241&publication_year=2018&author=Sallets%2CA&author=Robinson%2CS&author=Kardosh%2CA make?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-023-03433-3?format=refman&flavour=references pull in monthly?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexander%20A.%20Pieper making per month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexander%20A.%20Pieper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dan%20V.%20Spiegelman
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dan%20V.%20Spiegelman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mildred%20A.%20R.%20Felder
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mildred%20A.%20R.%20Felder%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Arika%20S.%20Feils
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Arika%20S.%20Feils%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Noah%20W.%20Tsarovsky's financial summary
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Noah%20W.%20Tsarovsky%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jen%20Zaborek?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jen%20Zaborek%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zachary%20S.%20Morris?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zachary%20S.%20Morris%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Amy%20K.%20Erbe?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Amy%20K.%20Erbe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexander%20L.%20Rakhmilevich earn?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexander%20L.%20Rakhmilevich%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Paul%20M.%20Sondel generate?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Paul%20M.%20Sondel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM1_ESM.tiff make?
- How much does https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM2_ESM.tiff rake in every month?
- What's the profit of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM3_ESM.tiff?
- What's the financial intake of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM4_ESM.tiff?
- What's the monthly money flow for https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM5_ESM.tiff?
- What's the financial gain of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM6_ESM.docx?
- Find out how much https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03433-3/MediaObjects/262_2023_3433_MOESM7_ESM.docx earns monthly
- What's the income generated by http://creativecommons.org/licenses/by/4.0/ each month?
- Revenue of https://s100.copyright.com/AppDispatchServlet?title=Factors%20impacting%20the%20efficacy%20of%20the%20in-situ%20vaccine%20with%20CpG%20and%20OX40%20agonist&author=Alexander%20A.%20Pieper%20et%20al&contentID=10.1007%2Fs00262-023-03433-3©right=The%20Author%28s%29&publication=0340-7004&publicationDate=2023-04-05&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
- How much revenue does https://crossmark.crossref.org/dialog/?doi=10.1007/s00262-023-03433-3 bring in?
- Income figures for https://citation-needed.springer.com/v2/references/10.1007/s00262-023-03433-3?format=refman&flavour=citation
- Find out how much https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral earns monthly
- Financial intake of https://www.springernature.com/gp/products
- Learn about the earnings of https://www.springernature.com/gp/librarians
- How much cash flow does https://www.springernature.com/gp/societies have monthly?
- How much does https://www.springernature.com/gp/partners rake in every month?
- How much does https://www.springer.com/ make?
- What's the revenue for https://www.nature.com/?
- How much does https://www.biomedcentral.com/ gross monthly?
- Earnings of https://www.palgrave.com/
- How much profit does https://www.apress.com/ make?
- Monthly income for https://www.springernature.com/gp/legal/ccpa
- What are the earnings of https://www.springernature.com/gp/info/accessibility?
- How much income is https://support.springernature.com/en/support/home earning monthly?
- See how much https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations makes per month
- How much does https://www.springernature.com/ pull in?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref